Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTO -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (7555)	7/22/1999 5:52:00 PM
From: ge	Read Replies (1) \| Respond to of 8116

O.T. Hi Rod. Do you still come back to this board?

To: Jim Oravetz who wrote (7555)	7/29/1999 7:24:00 PM
From: Jim Oravetz	Read Replies (2) \| Respond to of 8116

informaxinc.com good news today about Axcell. Maybe the partnership will lead to faster returns on thier knowledge base. InforMax has some pretty good customers in the drug biz: From the News site at informax As well as Glaxo Wellcome Plc, Zeneca and Rhone-Poulenc Rorer, Sweden's Astra AB , and DuPont Co and Pfizer Inc , of the U.S. use InforMax software an a worldwide basis, and last year its Vector NTI molecular biology programme won product of the year award from Biotechnology Software and Internet journal